Search Within

MALIGNANT MESOTHELIOMA

Malignant Mesothelioma Resistance to Apoptosis: Recent Discoveries and their Implication for Effective Therapeutic Strategies

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 7
Page: 631-641
Authors: M. R. Rippo, F. Villanova and A. Procopio

Molecular Targets and Targeted Therapies for Malignant Mesothelioma

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 9
Page: 855-867
Authors: Camilla Palumbo, Roberto Bei, Antonio Procopio and Andrea Modesti

Onconase and Amphinase, the Antitumor Ribonucleases from Rana pipiens Oocytes

Journal: Current Pharmaceutical Biotechnology
Volume: 9,Issue: 3
Page: 215-225
Authors: W. Ardelt, K. Shogen and Z. Darzynkiewicz

Antibody-Onconase Conjugates: Cytotoxicity and Intracellular Routing

Journal: Current Pharmaceutical Biotechnology
Volume: 9,Issue: 3
Page: 226-230
Authors: S. M. Rybak

Ribonucleases and ImmunoRNases as Anticancer Drugs

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 23
Page: 2665-2675
Authors: S. M. Rybak, M. A.E. Arndt, T. Schirrmann, S. Dubel and J. Krauss

Molecular Targets in Malignant Pleural Mesothelioma Treatment

Journal: Current Drug Targets
Volume: 10,Issue: 12
Page: 1235-1244
Authors: Giulia Pasello and Adolfo Favaretto

Predictive Markers for Haematological Toxicity of Pemetrexed

Journal: Current Drug Targets
Volume: 11,Issue: 1
Page: 48-57
Authors: S. C.H. Kao, V. H. Phan and S. J. Clarke

Biological Agents Involved in Malignant Mesothelioma: Relevance as Biomarkers or Therapeutic Targets

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 1
Page: 19-26
Authors: S. Crispi, I. Cardillo, E. P. Spugnini, G. Citro, S. Menegozzo and A. Baldi

Will Antiangiogenic Agents be a Future for Mesothelioma Therapy?

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 27
Page: 3069-3079
Authors: C. Belli, S. Anand, M. Panella, M. Giovannini, G. Tassi, D. Fennell and L. Mutti

Cox Inhibitors as Potential Chemotherapic Drugs for Mesothelioma

Journal: Current Respiratory Medicine Reviews
Volume: 3,Issue: 1
Page: 15-18
Authors: Enrico P. Spugnini, Gennaro Citro and Alfonso Baldi

Malignant Mesothelioma: Biology, Diagnosis and Therapeutic Approaches

Journal: Current Molecular Pharmacology
Volume: 2,Issue: 2
Page: 190-206
Authors: Marco Tomasetti, Monica Amati, Lory Santarelli, Renata Alleva and Jiri Neuzil

Histone Deacetylase Inhibitors as Potential Therapeutic Agents for the Treatment of Malignant Mesothelioma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 3
Page: 476-482
Authors: Patroklos Katafygiotis, Constantinos Giaginis, Efstratios Patsouris and Stamatios Theocharis

Malignant Mesothelioma: Cell Survival Pathways and Radiation Therapy

Journal: Current Respiratory Medicine Reviews
Volume: 11,Issue: 3
Page: 189-196
Authors: Mutlay Sayan, H. James Wallace III, Ruth Heimann and Brooke T. Mossman

First Molecular Cytogenetic Characterization of Murine Malignant Mesothelioma Cell Line AE17 and In Silico Translation to the Human Genome

Journal: Current Bioinformatics
Volume: 12,Issue: 1
Page: 11-18
Authors: Eva Kubicova, Vladimir Trifonov, Fran Borovecki, Thomas Liehr, Martina Rincic, Nadezda Kosyakova and Shaymaa S. Hussein

Investigations of Malignant Mesothelioma

Journal: Current Respiratory Medicine Reviews
Volume: 12,Issue: 3
Page: 208-214
Authors: Jack A. Kastelik, Mahmoud Loubani, Gerard Avery, Anthony G. Arnold and Jaymin Morjaria

Epidemiology and Pathology of Malignant Mesothelioma

Journal: Current Respiratory Medicine Reviews
Volume: 12,Issue: 4
Page: 271-276
Authors: Jack A. Kastelik, Mahmoud Loubani, Michael Greenstone, Simon Hart and Anne Campbell

The Role of Systemic Treatment and Radiotherapy in Malignant Mesothelioma

Journal: Current Respiratory Medicine Reviews
Volume: 12,Issue: 3
Page: 232-240
Authors: Michael Lind, Rachael Barton, Andrzej Wieczorek, Mahmoud Loubani and Jack A. Kastelik

Immune Checkpoints Aberrations and Malignant Mesothelioma: Assessment of Prognostic Value and Evaluation of Therapeutic Potentials

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 9
Page: 1228-1233
Authors: Hadeer Mohamed, Mostafa Eltobgy and Omar Abdel-Rahman*

Current and Emerging Therapy for Malignant Pleural Mesothelioma: Focus on CD26/Dipeptidyl Peptidase IV as a Therapeutic Target

Journal: Current Cancer Therapy Reviews
Volume: 13,Issue: 2
Page: 76-88
Authors: Bently P. Doonan, Kei Ohnuma, Long H. Dang, Chikao Morimoto and Nam H. Dang*